Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China

Abstract Background Toxoplasma gondii is an amphixenosis which has extensive hosts. In recent years, the prevalence of T. gondii in China has been reported, while little is known on the survey of T. gondii infection in northwest China, especially in yaks ( Bos grunniens ) and Tibetan mastiffs ( Cani...

Full description

Bibliographic Details
Main Authors: Wang, Meng, Wang, Yan-hua, Ye, Qiang, Meng, Peng, Yin, Hong, Zhang, De-lin
Format: Other/Unknown Material
Language:English
Published: BioMed Central Ltd. 2012
Subjects:
Yak
Online Access:http://www.parasitesandvectors.com/content/5/1/35
id ftbiomed:oai:biomedcentral.com:1756-3305-5-35
record_format openpolar
spelling ftbiomed:oai:biomedcentral.com:1756-3305-5-35 2023-05-15T15:49:51+02:00 Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China Wang, Meng Wang, Yan-hua Ye, Qiang Meng, Peng Yin, Hong Zhang, De-lin 2012-02-13 http://www.parasitesandvectors.com/content/5/1/35 en eng BioMed Central Ltd. http://www.parasitesandvectors.com/content/5/1/35 Copyright 2012 Wang et al.; licensee BioMed Central Ltd. Toxoplasma gondii Survey Tibetan mastiff Yak IHAT Research 2012 ftbiomed 2012-09-08T23:54:16Z Abstract Background Toxoplasma gondii is an amphixenosis which has extensive hosts. In recent years, the prevalence of T. gondii in China has been reported, while little is known on the survey of T. gondii infection in northwest China, especially in yaks ( Bos grunniens ) and Tibetan mastiffs ( Canis lupus familiaris ). The current study survey the infection of T. gondii in Tibetan mastiffs and yaks in Qinghai Province, China. Methods The indirect hemagglutination test (IHAT) was used to examine T. gondii antibodies in 1 795 serums, including 192 Tibetan mastiffs and 1603 yaks in Qinghai Province, China. Results In this study, the seroprevalence of T. gondii infection was 8.52%. Twenty (10.42%) of 192 serums of Tibetan mastiffs and 133 (8.30%) of 1603 serums of yaks were seropositive. The seroprevalence of T.gondii infection in Tibetan mastiffs in breeding farm (1.08%) was lower than that in the field (19.19%), and the difference was statistically significant ( P <0.05). The seroprevalence of antibodies to T.gondii in yaks ranged from 5.45% to 13.28% among the four different areas. The seroprevalence in different age groups were determined with apparent association. Conclusions The results indicated that T.gondii infection was prevalent in Tibetan mastiffs and yaks, which have implications for public health in this region. To our knowledge, this is the first seroprevalence survey of Tibetan mastiffs infected by T. gondii in The People’s Republic of China. Other/Unknown Material Canis lupus BioMed Central
institution Open Polar
collection BioMed Central
op_collection_id ftbiomed
language English
topic Toxoplasma gondii
Survey
Tibetan mastiff
Yak
IHAT
spellingShingle Toxoplasma gondii
Survey
Tibetan mastiff
Yak
IHAT
Wang, Meng
Wang, Yan-hua
Ye, Qiang
Meng, Peng
Yin, Hong
Zhang, De-lin
Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China
topic_facet Toxoplasma gondii
Survey
Tibetan mastiff
Yak
IHAT
description Abstract Background Toxoplasma gondii is an amphixenosis which has extensive hosts. In recent years, the prevalence of T. gondii in China has been reported, while little is known on the survey of T. gondii infection in northwest China, especially in yaks ( Bos grunniens ) and Tibetan mastiffs ( Canis lupus familiaris ). The current study survey the infection of T. gondii in Tibetan mastiffs and yaks in Qinghai Province, China. Methods The indirect hemagglutination test (IHAT) was used to examine T. gondii antibodies in 1 795 serums, including 192 Tibetan mastiffs and 1603 yaks in Qinghai Province, China. Results In this study, the seroprevalence of T. gondii infection was 8.52%. Twenty (10.42%) of 192 serums of Tibetan mastiffs and 133 (8.30%) of 1603 serums of yaks were seropositive. The seroprevalence of T.gondii infection in Tibetan mastiffs in breeding farm (1.08%) was lower than that in the field (19.19%), and the difference was statistically significant ( P <0.05). The seroprevalence of antibodies to T.gondii in yaks ranged from 5.45% to 13.28% among the four different areas. The seroprevalence in different age groups were determined with apparent association. Conclusions The results indicated that T.gondii infection was prevalent in Tibetan mastiffs and yaks, which have implications for public health in this region. To our knowledge, this is the first seroprevalence survey of Tibetan mastiffs infected by T. gondii in The People’s Republic of China.
format Other/Unknown Material
author Wang, Meng
Wang, Yan-hua
Ye, Qiang
Meng, Peng
Yin, Hong
Zhang, De-lin
author_facet Wang, Meng
Wang, Yan-hua
Ye, Qiang
Meng, Peng
Yin, Hong
Zhang, De-lin
author_sort Wang, Meng
title Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China
title_short Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China
title_full Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China
title_fullStr Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China
title_full_unstemmed Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China
title_sort serological survey of toxoplasma gondii in tibetan mastiffs (canis lupus familiaris) and yaks (bos grunniens) in qinghai, china
publisher BioMed Central Ltd.
publishDate 2012
url http://www.parasitesandvectors.com/content/5/1/35
genre Canis lupus
genre_facet Canis lupus
op_relation http://www.parasitesandvectors.com/content/5/1/35
op_rights Copyright 2012 Wang et al.; licensee BioMed Central Ltd.
_version_ 1766384862685560832